Knudsen Hannah K, Ducharme Lori J, Roman Paul M
Center for Research on Behavioral Health and Human Services Delivery, University of Georgia, Athens, GA 30602-2401, USA.
J Addict Dis. 2007;26(1):41-50. doi: 10.1300/J069v26n01_06.
Although non-medical use of controlled-release (CR) oxycodone is increasing, little is known about the substance abuse treatment facilities serving individuals dependent on this medication. This study examines the associations between the characteristics of treatment organizations and two dependent variables: any CR-oxycodone admissions and the number of CR-oxycodone admissions in the past six months. Face-to-face interviews were conducted with administrators of 363 publicly funded and 401 privately funded treatment centers in the US. Publicly funded non-profit organizations were less likely to have treated this population than government- owned, privately funded non-profit, and for-profit treatment centers. Some evidence indicated the availability of pharmacotherapies and detoxification services were associated with the dependent variables. Twelve-step programs were more likely to have treated oxycodone-dependent clients. Rural facilities treated significantly more clients than those in metropolitan areas. The high prevalence of CR-oxycodone admissions suggests the need for widespread training of treatment providers regarding treatment for CR-oxycodone dependence.
尽管缓释羟考酮的非医疗用途不断增加，但对于为依赖这种药物的个体提供服务的药物滥用治疗机构却知之甚少。本研究考察了治疗机构的特征与两个因变量之间的关联：任何缓释羟考酮入院治疗情况以及过去六个月内缓释羟考酮入院治疗的人数。对美国363家公共资助和401家私人资助的治疗中心的管理人员进行了面对面访谈。与政府所有、私人资助的非营利性和营利性治疗中心相比，公共资助的非营利性组织治疗该人群的可能性较小。一些证据表明，药物治疗和戒毒服务的可获得性与因变量相关。十二步戒毒康复项目治疗羟考酮依赖患者的可能性更大。农村治疗机构治疗的患者明显多于大都市地区的治疗机构。缓释羟考酮入院治疗的高发生率表明，需要对治疗提供者进行关于缓释羟考酮依赖治疗的广泛培训。
